Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia

Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.448
https://www.valueinhealthjournal.com/article/S1098-3015(13)02353-X/fulltext
Section Title : Disease-Specific Studies
Section Order : 429
First Page : A400
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02353-X&doi=10.1016/j.jval.2013.08.448
HEOR Topics :
Tags :
Regions :